Sep 1, 2026 09:07AM
Aug 4, 2026 07:38AM
Jul 30, 2026 04:53AM
Jun 1, 2026 01:53PM
May 22, 2026 07:30AM
May 22, 2026 07:30AM
May 21, 2026 04:28PM ImmunityBio, Inc. Securities Fraud Class Action Result of FDA Warning and 21% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
May 20, 2026 02:18PM
May 19, 2026 02:16PM
May 19, 2026 07:31AM
May 18, 2026 03:02PM
May 18, 2026 01:01PM
May 18, 2026 07:31AM
May 7, 2026 07:39AM ImmunityBio, Inc. (IBRX) Misses Q1 EPS by 55c
Apr 21, 2026 07:30AM
Apr 9, 2026 07:31AM
Apr 6, 2026 07:30AM
Mar 31, 2026 07:31AM
Mar 30, 2026 03:21PM
Mar 26, 2026 07:30AM
Mar 24, 2026 12:52PM BTIG on Immunitybio Inc (IBRX): FDA warning letter issue 'likely resolvable,' selloff a buying oppty
Mar 24, 2026 10:44AM
Mar 24, 2026 09:27AM
Mar 20, 2026 01:08PM
Mar 17, 2026 07:31AM
Mar 13, 2026 07:30AM
Mar 11, 2026 04:11PM
Mar 9, 2026 07:31AM ImmunityBio resubmits cancer treatment application to FDA
Mar 4, 2026 07:54AM
Feb 26, 2026 07:31AM
Feb 25, 2026 03:09PM
Feb 23, 2026 01:03PM
Feb 23, 2026 10:39AM
Feb 23, 2026 08:17AM
Feb 23, 2026 07:01AM ImmunityBio reports 700% revenue growth, expands approvals globally
Feb 20, 2026 08:30AM
Feb 19, 2026 09:02AM
Feb 18, 2026 09:01AM
Feb 17, 2026 06:09AM
Jan 26, 2026 06:49AM
Jan 23, 2026 07:00AM
Jan 22, 2026 01:17PM Immunitybio Inc (IBRX) PT Raised to $9 at BTIG
Jan 21, 2026 10:09AM
Jan 20, 2026 07:44AM
Jan 16, 2026 10:44AM
Jan 16, 2026 07:00AM
Jan 16, 2026 07:00AM
Jan 15, 2026 08:41AM
Jan 15, 2026 08:32AM ImmunityBio reports $113 million revenue, 700% annual increase
Jan 14, 2026 08:30AM

443,926 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All